Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tjarda M Boere"'
Autor:
Maurits W van Tulder, Cees M P M Hertogh, Judith E Bosmans, Theo J M Verheij, Rogier M Hopstaken, Mohamed El Alili, Tjarda M Boere, Laura W van Buul
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Objectives C-reactive protein point-of-care testing (CRP POCT) is a promising diagnostic tool to guide antibiotic prescribing for lower respiratory tract infections (LRTI) in nursing home residents. This study aimed to evaluate cost-effectiveness and
Externí odkaz:
https://doaj.org/article/b5ae43671dee4daab3fef451d62b008f
Autor:
Tjarda M. Boere, Laura W. van Buul, Rogier M. Hopstaken, Ruth B. Veenhuizen, Maurits W. van Tulder, Jochen W. L. Cals, Theo J. M. Verheij, Cees M. P. M. Hertogh
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Antibiotics are over-prescribed for lower respiratory tract infections (LRTI) in nursing home residents due to diagnostic uncertainty. Inappropriate antibiotic use is undesirable both on patient level, considering their exposure t
Externí odkaz:
https://doaj.org/article/7fb70f475f88424b827f69c4de961053
Autor:
Tjarda M Boere, Mohamed El Alili, Laura W van Buul, Rogier M Hopstaken, Theo J M Verheij, Cees M P M Hertogh, Maurits W van Tulder, Judith E Bosmans
Publikováno v:
BMJ Open, 12(9):e055234. BMJ Publishing Group
BMJ Open. BMJ Publishing Group
Boere, T M, El Alili, M, Van Buul, L W, Hopstaken, R M, Verheij, T J M, Hertogh, C M P M, Van Tulder, M W & Bosmans, J E 2022, ' Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes : A cluster randomised trial ', BMJ Open, vol. 12, no. 9, e055234, pp. 1-10 . https://doi.org/10.1136/bmjopen-2021-055234, https://doi.org/10.1136/bmjopen-2021-055234
BMJ Open, 12(9):e055234, 1-10. BMJ Publishing Group
Boere, T M, el Alili, M, van Buul, L W, Hopstaken, R M, Verheij, T J M, Hertogh, C M P M, van Tulder, M W & Bosmans, J E 2022, ' Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes : a cluster randomised trial ', BMJ Open, vol. 12, no. 9, e055234, pp. e055234 . https://doi.org/10.1136/bmjopen-2021-055234
BMJ Open. BMJ Publishing Group
Boere, T M, El Alili, M, Van Buul, L W, Hopstaken, R M, Verheij, T J M, Hertogh, C M P M, Van Tulder, M W & Bosmans, J E 2022, ' Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes : A cluster randomised trial ', BMJ Open, vol. 12, no. 9, e055234, pp. 1-10 . https://doi.org/10.1136/bmjopen-2021-055234, https://doi.org/10.1136/bmjopen-2021-055234
BMJ Open, 12(9):e055234, 1-10. BMJ Publishing Group
Boere, T M, el Alili, M, van Buul, L W, Hopstaken, R M, Verheij, T J M, Hertogh, C M P M, van Tulder, M W & Bosmans, J E 2022, ' Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes : a cluster randomised trial ', BMJ Open, vol. 12, no. 9, e055234, pp. e055234 . https://doi.org/10.1136/bmjopen-2021-055234
ObjectivesC-reactive protein point-of-care testing (CRP POCT) is a promising diagnostic tool to guide antibiotic prescribing for lower respiratory tract infections (LRTI) in nursing home residents. This study aimed to evaluate cost-effectiveness and
Autor:
Laura W van Buul, Tjarda M Boere, Theo J M Verheij, Maurits W. van Tulder, Rogier M. Hopstaken, Franҫois G Schellevis, Cees M.P.M. Hertogh
Publikováno v:
Journal of the American Medical Directors Association. Elsevier Inc.
Journal of the American Medical Directors Association, 23(6), 968-975.e3. Elsevier Inc.
Boere, T M, Hopstaken, R M, van Tulder, M W, Schellevis, F G, Verheij, T J M, Hertogh, C M P M & van Buul, L W 2021, ' Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes ', Journal of the American Medical Directors Association . https://doi.org/10.1016/j.jamda.2021.09.010
Boere, T M, Hopstaken, R M, van Tulder, M W, Schellevis, F G, Verheij, T J M, Hertogh, C M P M & van Buul, L W 2022, ' Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes ', Journal of the American Medical Directors Association, vol. 23, no. 6, pp. 968-975.e3 . https://doi.org/10.1016/j.jamda.2021.09.010
Journal of the American Medical Directors Association, 23(6), 968-975.e3. Elsevier Inc.
Boere, T M, Hopstaken, R M, van Tulder, M W, Schellevis, F G, Verheij, T J M, Hertogh, C M P M & van Buul, L W 2021, ' Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes ', Journal of the American Medical Directors Association . https://doi.org/10.1016/j.jamda.2021.09.010
Boere, T M, Hopstaken, R M, van Tulder, M W, Schellevis, F G, Verheij, T J M, Hertogh, C M P M & van Buul, L W 2022, ' Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes ', Journal of the American Medical Directors Association, vol. 23, no. 6, pp. 968-975.e3 . https://doi.org/10.1016/j.jamda.2021.09.010
OBJECTIVES: This study evaluated logistics, process data, and barriers/facilitators for the implementation and use of C-reactive protein point-of-care testing (CRP POCT) for suspected lower respiratory tract infections (LRTIs) in nursing home (NH) re
Autor:
Theo J M Verheij, Maurits W. van Tulder, Tjarda M Boere, Jos W M R Twisk, Rogier M. Hopstaken, Laura W van Buul, Cees M.P.M. Hertogh
Publikováno v:
The BMJ
Boere, T M, van Buul, L W, Hopstaken, R M, van Tulder, M W, Twisk, J W M R, Verheij, T J M & Hertogh, C M P M 2021, ' Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents : Cluster randomised controlled trial ', The BMJ, vol. 374, n2198 . https://doi.org/10.1136/bmj.n2198
BMJ (Clinical research ed.), 374:n2198, 1-8. BMJ Publishing Group
BMJ (e), 374:n2198. BMJ Publishing Group
The BMJ, 374:n2198. BMJ Publishing Group
Boere, T M, van Buul, L W, Hopstaken, R M, van Tulder, M W, Twisk, J W M R, Verheij, T J M & Hertogh, C M P M 2021, ' Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents : cluster randomised controlled trial ', BMJ (Clinical research ed.), vol. 374, n2198, pp. 1-8 . https://doi.org/10.1136/bmj.n2198
Boere, T M, van Buul, L W, Hopstaken, R M, van Tulder, M W, Twisk, J W M R, Verheij, T J M & Hertogh, C M P M 2021, ' Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents : Cluster randomised controlled trial ', The BMJ, vol. 374, n2198 . https://doi.org/10.1136/bmj.n2198
BMJ (Clinical research ed.), 374:n2198, 1-8. BMJ Publishing Group
BMJ (e), 374:n2198. BMJ Publishing Group
The BMJ, 374:n2198. BMJ Publishing Group
Boere, T M, van Buul, L W, Hopstaken, R M, van Tulder, M W, Twisk, J W M R, Verheij, T J M & Hertogh, C M P M 2021, ' Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents : cluster randomised controlled trial ', BMJ (Clinical research ed.), vol. 374, n2198, pp. 1-8 . https://doi.org/10.1136/bmj.n2198
Objective To evaluate whether C reactive protein point-of-care testing (CRP POCT) safely reduces antibiotic prescribing for lower respiratory tract infections in nursing home residents. Design Pragmatic, cluster randomised controlled trial. Setting T
Autor:
Tjarda M Boere, Laura W van Buul, Rogier M. Hopstaken, Maurits W. van Tulder, Ruth B. Veenhuizen, Jochen W L Cals, Cees M.P.M. Hertogh, Theo J M Verheij
Publikováno v:
Boere, T M, van Buul, L W, Hopstaken, R M, Veenhuizen, R B, van Tulder, M W, Cals, J W L, Verheij, T J M & Hertogh, CMPM 2020, ' Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE) : study design of a cluster randomized controlled trial ', BMC Health Services Research, vol. 20, no. 1, 149 . https://doi.org/10.1186/s12913-020-5006-0
Boere, T M, van Buul, L W, Hopstaken, R M, Veenhuizen, R B, van Tulder, M W, Cals, J W L, Verheij, T J M & Hertogh, C M P M 2020, ' Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE) : study design of a cluster randomized controlled trial ', BMC Health Services Research, vol. 20, no. 1, 149, pp. 149 . https://doi.org/10.1186/s12913-020-5006-0
BMC Health Services Research
BMC Health Services Research, 20(1):149. BioMed Central
BMC Health Services Research, 20(149):149, 1-8. BioMed Central Ltd
BMC Health Services Research, Vol 20, Iss 1, Pp 1-8 (2020)
Boere, T M, van Buul, L W, Hopstaken, R M, Veenhuizen, R B, van Tulder, M W, Cals, J W L, Verheij, T J M & Hertogh, C M P M 2020, ' Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE) : study design of a cluster randomized controlled trial ', BMC Health Services Research, vol. 20, no. 1, 149, pp. 149 . https://doi.org/10.1186/s12913-020-5006-0
BMC Health Services Research
BMC Health Services Research, 20(1):149. BioMed Central
BMC Health Services Research, 20(149):149, 1-8. BioMed Central Ltd
BMC Health Services Research, Vol 20, Iss 1, Pp 1-8 (2020)
BackgroundAntibiotics are over-prescribed for lower respiratory tract infections (LRTI) in nursing home residents due to diagnostic uncertainty. Inappropriate antibiotic use is undesirable both on patient level, considering their exposure to side eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2802365ef3220abe2d9f40b5baa87e
https://research.vumc.nl/en/publications/d0022df1-ca46-4425-a7d0-605478edd61c
https://research.vumc.nl/en/publications/d0022df1-ca46-4425-a7d0-605478edd61c
Publikováno v:
European Respiratory Journal, 49(6):1601979. European Respiratory Society
European respiratory journal, 49(6). European Respiratory Society
Boere, T M, Visser, D H, Van Furth, A M, Lips, P & Cobelens, F G J 2017, ' Solar ultraviolet B exposure and global variation in tuberculosis incidence : An ecological analysis ', European Respiratory Journal, vol. 49, no. 6, 1601979 . https://doi.org/10.1183/13993003.01979-2016
European respiratory journal, 49(6). European Respiratory Society
Boere, T M, Visser, D H, Van Furth, A M, Lips, P & Cobelens, F G J 2017, ' Solar ultraviolet B exposure and global variation in tuberculosis incidence : An ecological analysis ', European Respiratory Journal, vol. 49, no. 6, 1601979 . https://doi.org/10.1183/13993003.01979-2016
Epidemiological evidence supports vitamin D deficiency as a risk factor for tuberculosis. Differences in solar ultraviolet B (UV-B) exposure, the major source of vitamin D, might therefore partially explain global variation in tuberculosis incidence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6aa7a38fd7a0744e9b318e4f1bb1ae
https://research.vu.nl/en/publications/a928ce91-cacf-4a15-90da-f31e35de66a8
https://research.vu.nl/en/publications/a928ce91-cacf-4a15-90da-f31e35de66a8